The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors



Status:Completed
Conditions:Breast Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/8/2018
Start Date:November 30, 2015
End Date:January 24, 2018

Use our guide to learn which trials are right for you!

Randomized Controlled Trial of Sitting Time Interventions in Breast Cancer Survivors

Excessive sitting time (sedentary time) has been associated with risk of insulin resistance
and other factors which may be relevant to breast cancer prognosis. This 8-week study tests
different strategies for helping breast cancer survivors to modify their levels of sitting
time. Participants will be assigned with equal likelihood to one of three groups (1) overall
reduction in sitting time, (2) interruption of sitting time with standing breaks, and (3)
usual care.


Inclusion Criteria:

1. diagnosed with Stage 0-III breast cancer. Bilateral or multiple primary breast cancers
are permitted.

2. Completed primary treatment defined as definitive surgery, (neo)adjuvant chemotherapy
and/or (neo)adjuvant radiation. Participants still receiving adjuvant endocrine or
HER2 targeted therapies are eligible.

3. Report sitting for ≥8 accumulated waking hours on a typical day,

4. Willing and able to attend 3 study visits at the UW,

5. Willing to attempt reduction of sitting time,

6. Use the internet on a regular basis,

7. Willing and able to complete study requirements, and

8. Currently considered postmenopausal (no menstrual periods in past 12 months), even if
pre-menopausal at diagnosis.

Exclusion Criteria:

1. Evidence of recurrence or metastatic disease,

2. Unable to move from sitting to standing without difficulty and to walk 1 block.
We found this trial at
1
site
Madison, Wisconsin
?
mi
from
Madison, WI
Click here to add this to my saved trials